Cargando…
The disease burden of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 in a predominantly vaccinated and healthy cohort
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444149/ https://www.ncbi.nlm.nih.gov/pubmed/36067942 http://dx.doi.org/10.1016/j.cmi.2022.08.019 |
_version_ | 1784783152519053312 |
---|---|
author | Sendi, Parham Branca, Mattia Büchi, Annina Elisabeth Widmer, Nadja Tande, Aaron J. Gowland, Peter |
author_facet | Sendi, Parham Branca, Mattia Büchi, Annina Elisabeth Widmer, Nadja Tande, Aaron J. Gowland, Peter |
author_sort | Sendi, Parham |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9444149 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94441492022-09-06 The disease burden of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 in a predominantly vaccinated and healthy cohort Sendi, Parham Branca, Mattia Büchi, Annina Elisabeth Widmer, Nadja Tande, Aaron J. Gowland, Peter Clin Microbiol Infect Letter to the Editor European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022-12 2022-09-05 /pmc/articles/PMC9444149/ /pubmed/36067942 http://dx.doi.org/10.1016/j.cmi.2022.08.019 Text en © 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Sendi, Parham Branca, Mattia Büchi, Annina Elisabeth Widmer, Nadja Tande, Aaron J. Gowland, Peter The disease burden of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 in a predominantly vaccinated and healthy cohort |
title | The disease burden of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 in a predominantly vaccinated and healthy cohort |
title_full | The disease burden of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 in a predominantly vaccinated and healthy cohort |
title_fullStr | The disease burden of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 in a predominantly vaccinated and healthy cohort |
title_full_unstemmed | The disease burden of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 in a predominantly vaccinated and healthy cohort |
title_short | The disease burden of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 in a predominantly vaccinated and healthy cohort |
title_sort | disease burden of delta and omicron variants of severe acute respiratory syndrome coronavirus 2 in a predominantly vaccinated and healthy cohort |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444149/ https://www.ncbi.nlm.nih.gov/pubmed/36067942 http://dx.doi.org/10.1016/j.cmi.2022.08.019 |
work_keys_str_mv | AT sendiparham thediseaseburdenofdeltaandomicronvariantsofsevereacuterespiratorysyndromecoronavirus2inapredominantlyvaccinatedandhealthycohort AT brancamattia thediseaseburdenofdeltaandomicronvariantsofsevereacuterespiratorysyndromecoronavirus2inapredominantlyvaccinatedandhealthycohort AT buchianninaelisabeth thediseaseburdenofdeltaandomicronvariantsofsevereacuterespiratorysyndromecoronavirus2inapredominantlyvaccinatedandhealthycohort AT widmernadja thediseaseburdenofdeltaandomicronvariantsofsevereacuterespiratorysyndromecoronavirus2inapredominantlyvaccinatedandhealthycohort AT tandeaaronj thediseaseburdenofdeltaandomicronvariantsofsevereacuterespiratorysyndromecoronavirus2inapredominantlyvaccinatedandhealthycohort AT gowlandpeter thediseaseburdenofdeltaandomicronvariantsofsevereacuterespiratorysyndromecoronavirus2inapredominantlyvaccinatedandhealthycohort AT thediseaseburdenofdeltaandomicronvariantsofsevereacuterespiratorysyndromecoronavirus2inapredominantlyvaccinatedandhealthycohort AT sendiparham diseaseburdenofdeltaandomicronvariantsofsevereacuterespiratorysyndromecoronavirus2inapredominantlyvaccinatedandhealthycohort AT brancamattia diseaseburdenofdeltaandomicronvariantsofsevereacuterespiratorysyndromecoronavirus2inapredominantlyvaccinatedandhealthycohort AT buchianninaelisabeth diseaseburdenofdeltaandomicronvariantsofsevereacuterespiratorysyndromecoronavirus2inapredominantlyvaccinatedandhealthycohort AT widmernadja diseaseburdenofdeltaandomicronvariantsofsevereacuterespiratorysyndromecoronavirus2inapredominantlyvaccinatedandhealthycohort AT tandeaaronj diseaseburdenofdeltaandomicronvariantsofsevereacuterespiratorysyndromecoronavirus2inapredominantlyvaccinatedandhealthycohort AT gowlandpeter diseaseburdenofdeltaandomicronvariantsofsevereacuterespiratorysyndromecoronavirus2inapredominantlyvaccinatedandhealthycohort AT diseaseburdenofdeltaandomicronvariantsofsevereacuterespiratorysyndromecoronavirus2inapredominantlyvaccinatedandhealthycohort |